[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.240.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
1.
Smith  AD Homocysteine, B vitamins and cognitive deficits in the elderly.  Am J Clin Nutr 2002;75785- 786PubMedGoogle Scholar
2.
Toole  JFJack  CR Food (and vitamins) for thought.  Neurology 2002;581449- 1450PubMedGoogle ScholarCrossref
3.
Boushey  CJBeresford  SAOmenn  GSMotulsky  AG A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes.  JAMA 1995;2741049- 1057PubMedGoogle ScholarCrossref
4.
Moller  JNielsen  GMTvedegaard  KCAndersen  NTJorgensen  PE A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia.  Scand J Clin Lab Invest 2000;60491- 500PubMedGoogle ScholarCrossref
5.
Fassbender  KMielke  OBertsch  T  et al.  Homocysteine in cerebral macroangiography and microangiopathy.  Lancet 1999;3531586- 1587PubMedGoogle ScholarCrossref
6.
Hogervorst  ERibiero  HMMolyneux  ABudge  MSmith  D Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease.  Arch Neurol 2002;59787- 793PubMedGoogle ScholarCrossref
7.
Sachdev  PSValenzuela  MBrodaty  H  et al.  Homocysteine as a risk factor for cognitive impairment in stroke patients.  Dement Geriatr Cogn Disord 2003;15155- 162PubMedGoogle ScholarCrossref
8.
Sachdev  PSValenzuela  MWang  XLLooi  JCLBrodaty  H Relationship between plasma homocysteine levels and brain atrophy in health elderly individuals.  Neurology 2002;581539- 1541PubMedGoogle ScholarCrossref
9.
Bleich  SKornhuber  J Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals.  Neurology 2003;601220PubMedGoogle ScholarCrossref
10.
Clarke  RSmith  DAJobst  KA  et al.  Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.  Arch Neurol 1998;551449- 1455PubMedGoogle ScholarCrossref
11.
Seshadri  SBeiser  ASelhub  J  et al.  Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease.  N Engl J Med 2002;346476- 483PubMedGoogle ScholarCrossref
12.
Reutens  SSachdev  P Homocysteine in neuropsychiatric disorders of the elderly.  Int J Geriatr Psychiatry 2002;17859- 864PubMedGoogle ScholarCrossref
13.
Looi  JCLSachdev  P Vascular dementia as a frontal subcortical system dysfunction.  Psychol Med 2000;30997- 1003PubMedGoogle ScholarCrossref
14.
Kado  DSelhub  JSeeman  TE Plasma total homocysteine levels and cognitive function in older high functioning adults: Macarthur Studies of Successful Aging.  J Am Geriatr Soc 2001;49S13Google Scholar
15.
Kalmijin  SLauner  LJLindemans  JBots  MLHofman  ABreteler  MM Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study.  Am J Epidemiol 1999;150283- 289PubMedGoogle ScholarCrossref
16.
McCaddon  AHudson  PDavies  GHughes  AWilliams  JHHWilkinson  C Homocysteine and cognitive decline in healthy elderly people.  Dement Geriatr Cogn Disord 2001;12309- 313PubMedGoogle ScholarCrossref
17.
Tsai  JCPerrella  MAYoshizumi  M  et al.  Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.  Proc Natl Acad Sci U S A 1994;916369- 6373PubMedGoogle ScholarCrossref
18.
Durand  PProst  MLoreau  NLussier-Cacan  SBlache  D Impaired homocysteine metabolism and atherothrombotic disease.  Lab Invest 2001;81645- 672PubMedGoogle ScholarCrossref
19.
Tawakol  AOmland  TGerhard  MWu  JT Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.  Circulation 1997;951119- 1121PubMedGoogle ScholarCrossref
20.
Kim  W-KPae  Y-S Involvement of N-methyl-D-aspartate receptor and free radical in homocysteine-medicated toxicity on rat cerebellar granule cells.  Neurosci Lett 1996;216117- 120PubMedGoogle Scholar
21.
Ho  PIOrtiz  DRogers  EShea  TB Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage.  J Neurosci Res 2002;70694- 702PubMedGoogle ScholarCrossref
22.
Kruman  IICulmsee  CChan  SL  et al.  Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity.  J Neurosci 2000;206920- 6936PubMedGoogle Scholar
23.
Vafai  SStock  JB Protein phosphatase 2A methylation: a link between elevated plasma homocysteine and Alzheimer's disease.  FEBS Lett 2002;5181- 4PubMedGoogle ScholarCrossref
24.
Ho  PICollins  SCDhitavat  S  et al.  Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress.  J Neurochem 2001;78249- 253PubMedGoogle ScholarCrossref
25.
Baddeley  AEmslie  HNimmo-Smith  I The Spot-the-Word Test.  Bury St Edmunds, England: Thames Valley Test Co; 1992
26.
Victoroff  JMack  WJGrafton  STSchreiber  SSChui  HC A method to improve interrater reliability of visual inspection of brain MRI scans in dementia.  Neurology 1994;442267- 2276PubMedGoogle ScholarCrossref
27.
Wen  WSachdev  PS The topography of white matter hyperintensities on brain MRI in middle-aged individuals.  Neuroimage 2004;22141- 154Google ScholarCrossref
28.
Fazekas  FChawluk  JBAlavi  AHurtig  HIZimmerman  RA MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging.  AJR Am J Roentgenol 1987;149351- 356Google ScholarCrossref
29.
Jorm  AFAnstey  KJChristensen  HRodgers  B Gender differences in cognitive abilities: the mediating role of health state and health habits.  Intelligence 2004;327- 23Google ScholarCrossref
30.
Smith  A Symbol Digit Modalities Test (SDMT) Manual.  Los Angeles, Calif: Western Psychological Services; 1982
31.
Delis  DCKramer  JHKaplan  EOber  BA California Verbal Learning Test.  San Antonio, Tex: Psychological Corp Harcourt Brace Jovanovich; 1987
32.
Tiffin  J Purdue Pegboard Examiner’s Manual.  Rosemont, Ill: London House; 1968
33.
Folstein  MFFolstein  SEMcHugh  PR “Mini-Mental State”: a practical method for grading the cognitive status of patients for the clinician.  J Psychiatr Res 1975;12189- 198PubMedGoogle ScholarCrossref
34.
den Heijer  MVermeer  SEClarke  R  et al.  Homocysteine and brain atrophy on MRI of non-demented elderly.  Brain 2003;126170- 175PubMedGoogle ScholarCrossref
35.
Williams  JHPereira  EACBudge  MMBradley  KM Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people.  Age Ageing 2002;31440- 444PubMedGoogle ScholarCrossref
36.
Pantoni  LGarcia  JH Pathogenesis of leukoaraiosis: a review.  Stroke 1997;28652- 659PubMedGoogle ScholarCrossref
37.
Fazekas  FKleinhert  ROffenbacher  H  et al.  Pathologic correlates of incidental MRI white matter signal hyperintensities.  Neurology 1993;431683- 1689PubMedGoogle ScholarCrossref
38.
Takao  MKoto  ATanahashi  N  et al.  Pathologic findings of silent hyperintense white matter lesions on MRI.  J Neurol Sci 1999;167127- 131PubMedGoogle ScholarCrossref
Original Contribution
September 2004

Homocysteine and the Brain in Midadult Life: Evidence for an Increased Risk of Leukoaraiosis in Men

Author Affiliations

Author Affiliations: School of Psychiatry, University of New South Wales, Sydney, Australia (Drs Sachdev and Wen); Neuropsychiatric Institute, The Prince of Wales Hospital, Randwick, Australia (Drs Sachdev and Wen); the Centre for Mental Health Research, Australian National University, Canberra (Drs Parslow, Kumar, Christensen, and Jorm); and Clinical Chemistry, South Eastern Area Laboratory Services, Randwick (Mr Salonikas and Drs Lux and Naidoo).

Arch Neurol. 2004;61(9):1369-1376. doi:10.1001/archneur.61.9.1369
Abstract

Background  High serum homocysteine (HCY) levels have been associated with thromboembolic cerebrovascular disease, but their relationship to microvascular disease is uncertain. Homocysteine also has a direct neurotoxic effect and has been linked to brain atrophy and an increased risk of Alzheimer disease.

Objective  To examine the relationship of HCY levels to brain and cognitive measures in a healthy community sample.

Design  Cross-sectional study.

Setting  Individuals residing in Canberra and Queanbeyan, Australia, who were participating in the longitudinal PATH Through Life Project.

Participants  Individuals aged 60 to 64 years selected randomly from the community, 196 men and 189 women.

Main Outcome Measures  Regression coefficients with HCY level as the putative determinant and various magnetic resonance imaging measures (brain atrophy index, ventricle-brain ratios, volume of periventricular and deep white matter hyperintensities) and cognitive measures (information processing speed, verbal memory, fine motor speed) as dependent measures.

Results  Homocysteine levels did not have a significant relationship with brain atrophy index or ventricle-brain ratios. High HCY levels were related to increased deep white matter hyperintensities but not periventricular white matter hyperintensities, after correcting for levels of folate, vitamin B12, creatinine, and thyrotropin; hypertension; smoking; and diabetes, the relationship being significant only in men. Homocysteine levels were related to impairment in verbal memory and fine motor speed but not after the previously mentioned correction.

Conclusions  Total HCY level is independently related to leukoaraiosis in middle-aged men, and this may be functionally relevant in the form of mild cognitive impairment. The remediation of hyperhomocysteinemia should begin early in life if its deleterious effects on the brain are to be prevented.

×